Regulation of tubulointerstitial crosstalk by microRNAs in renal fibrosis

(请保存在Word中，不要保存为PDF) 据估计，美国有3700万人(占总人口的15%)患有慢性肾脏疾病。目前还没有特定的干预措施来减缓慢性肾脏疾病的进展，这种疾病最终会导致肾衰竭，需要进行肾移植或透析。不管潜在的病因如何，进展中的CKD最终导致不可逆转的肾单位丢失和肾脏纤维化。纤维化是损伤后触发的正常修复过程的一部分，该过程的失调会导致细胞外基质蛋白的病理性堆积，主要是胶原蛋白。目前的治疗方法效果有限，最多只能延缓慢性肾脏疾病的进展。了解肾纤维化早期ECM蛋白积聚的分子机制将为CKD的新治疗方法提供信息。本实验室首次证实，miR-17~92簇(包括miR-17、miR-18、miR-19a、miR-19b、miR-20a和miR-92a)在小鼠肾祖细胞及其衍生物中的条件性缺失可导致小鼠肾发育不良和慢性肾脏疾病。我们现在有初步的数据表明，成人肾上皮细胞中miR-17~92的诱导性缺失会增加肾脏纤维化的易感性，相反，成人肾上皮细胞中miR-17~92的诱导性增加对肾脏纤维化具有保护作用。我们的中心假设是，肾上皮细胞中的miR-17~92具有限制肾纤维化的作用。为了验证这一假设，我们建议确定miR-17~92簇是否足以保护小鼠肾脏纤维化。

(PLEASE KEEP IN WORD, DO NOT PDF) An estimated 37 million people (15% of the population) in the United States have chronic kidney disease. There are currently no specific interventions to decrease the progression of chronic kidney disease, which ultimately leads to renal failure necessitating kidney transplant or dialysis. Regardless of underlying etiology, advancing CKD ultimately results in irreversible nephron loss and renal fibrosis. Fibrosis is part of the normal repair process triggered in response to injury, and dysregulation of this process results in the pathological accumulation of extracellular matrix proteins, primarily collagens. Current therapies have limited effectiveness and at most delay the progression of chronic kidney disease. Understanding the molecular mechanisms that drive the early accumulation of ECM proteins in renal fibrosis will inform novel therapeutic approaches to CKD. Our laboratory was the first to demonstrate that conditional loss of the miR-17~92 cluster (comprised of miR-17, miR-18, miR-19a, miR-19b, miR-20a and miR-92a) in nephron progenitors and their derivatives results in renal hypodysplasia and chronic kidney disease in mice. We now have preliminary data that inducible loss of miR-17~92 in adult renal epithelia results in increased susceptibility to renal fibrosis, and conversely that inducible gain of miR-17~92 in adult renal epithelia is protective against renal fibrosis. Our central hypothesis is that miR-17~92 in renal epithelia functions to limit renal fibrosis. To test this hypothesis, we propose to determine whether the miR-17~92 cluster is sufficient to protect against renal fibrosis in mice.